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LETTERS TO THE EDITORTo the Editor—Altered in vivo systolic
function in the short QT syndrome
anticipated in silicoA recent article by Frea et al1 in HeartRhythm provides new
evidence for altered systolic function in patients with the
short QT syndrome (SQTS). They studied 15 patients with
the SQTS (7 with the hERG mutation–linked SQT1 variant,
3 with KCNQ1 mutation–linked SQT2 variant, and 5 with-
out known mutations) by using tissue Doppler imaging and
speckle tracking electrocardiography to reveal reduced left
ventricular contraction and increased mechanical dispersion
in the SQTS group as compared with healthy controls.1
A longer myocardial performance index was seen in patients
with the SQTS, but without significant alterations in iso-
volumetric contraction and relaxation times, implying that
this results from reduced ejection time. Over half of the
patients with the SQTS also displayed pathological values of
global longitudinal shortening, which correlated positively
with corrected QT interval shortening.1 Mechanical disper-
sion affected the final stage of contraction in patients with the
SQTS.1
In 2013, we published a simulation study in which the
functional effects of SQTS Kþ channel mutations were
incorporated into human ventricular electromechanical
models.2 The incorporation of the SQT1 N588K hERG
mutation profoundly reduced the intracellular calcium
transient, leading to greatly reduced active force. The
SQT3 D172N Kir2.1 mutation, which predominantly
influences late repolarization, produced a more modest
effect.2 Once stretch-activated channels (SACs) were
incorporated into the base model, the effects of the SQT
mutations on the Ca2þ transient and force generation were
reduced and reduced further if SAC Ca2þ permeability was
incorporated.2 Under simulated action potential clamp,
shorter action potentials led to a reduced sarcoplasmic
reticulum Ca2þ content and Ca2þ transients in the control
model, implicating abbreviated repolarization itself as a
driver of altered contractility; the mitigating effects of SAC
incorporation correlated with changes in Naþ homeostasis
and sodium-calcium exchange (NCX) activity.2 The extent
to which mechanisms demonstrated in our “proof-of-
concept” simulations, made in the absence of any com-
pensatory remodeling, apply to the modest but significant
systolic dysfunction in patients with the SQTS1 remains to
be established. However, given the important findings of
Frea et al,1 further investigation of altered mechanical
function in the SQTS is now warranted.
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Physiol 2013;4:166.Reply to the Editor—Altered in vivo
systolic function in the short QT syndrome
anticipated in silicoOur group recently demonstrated an in vivo association
between short QT syndrome (SQTS) and a slight but
significant systolic dysfunction.1 Hancox and colleagues2
partially anticipated this report showing an interesting
correlation between SQTS channel mutations (mostly HERG
mutation) and shortening of action potential with an in vitro
reduction in Ca2þ transient and force generation.
These 2 studies seem to suggest that the association
between SQTS and systolic impairment may be explained by
3 mechanisms: a greater mechanical dispersion, a shorter
ejection time, and the presence of specific gene mutations.
In order to assess the relevance of each mechanism on the
development of systolic impairment, we performed some
further analysis of our data. First, we saw that a greater
mechanical dispersion correlated with a lower global long-
itudinal strain (r ¼ 0.493; P o .001) and a lower ejection
fraction (r ¼ 0.393; P ¼ .032). Second, a shorter left
ventricular ejection time, a mechanical consequence of a
reduced action potential duration, correlated with a lower
global longitudinal strain (r ¼ 0.474; P ¼ .008) and a lower
ejection fraction (r ¼ 0.381; P ¼ .038). Notably both
mechanical dispersion and ejection time correlated with
QT interval (r ¼ 0.404; P o .05 and r ¼ 0.397; P ¼ .03,
respectively). In other words, a short QT interval, increasing
mechanical dispersion and reducing ejection time, seems to
be the leading cause of the systolic dysfunction identified.
Third, by comparing patients with and without HERGhttp://dx.doi.org/10.1016/j.hrthm.2015.06.035
Heart Rhythm, Vol 12, No 9, September 2015e116mutations, we failed to find any significant difference. How-
ever, the higher use of hydroquinidine in patients with
HERG mutations (7 of 7 patients with HERG mutations
vs 4 of 8 patients without HERG mutations; P ¼ .05) could
have leveled off the results, especially considering that
the hydroquinidine effect is more relevant in patients
with HERG mutations.3 Further investigation is needed to
confirm this hypothesis.
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esophageal lesions after atrial fibrillation
ablation related to the use of esophageal
temperature probesThe article illustrates an experiment aimed at checking
whether it is safe and advisable to use esophageal probes
equipped with thermal sensors during radiofrequency abla-
tion procedures for pulmonary vein isolation. To this end,
2 cohorts of 40 patients each were treated with or without the
probe (Sensitherm, FIAB SpA), and an endoscopic analysis
was then performed to evaluate the incidence of esophageal
lesions in the 2 groups. The experiment seems to have been
carried out as rigorously as possible, but the conclusions
are misleading. The result that 12 patients in the group
with thermal control had esophageal “lesions” while only
1 patient with injury was detected in the other group is
perhaps technically correct but substantially wrong, since 10
of the 12 lesions were simple erythemas. The 3 patients with
ulcers found were split 2:1, which is not statistically
significant. Erythemas are asymptomatic and self-healing
irritations, usually not included in lesions. The mechanical
action of a probe on an abnormally heated (4401C) eso-
phageal mucosa may produce some irritation, but with no
consequences for patients. The authors quote experimentsproving that metallic bodies in tissues may infer lesions
when exposed to powerful RF fields. However, this is not our
case. Such a circumstance has been confirmed, for example,
in the recent article1 by means of a mathematical model.
Moreover, calculations performed at FIAB have shown that
in normal cases the maximal power dissipated on a sensor
ring of the probe is just of the order of 108 W (blood
strongly attracts the electric field lines carrying away a large
amount of the supplied energy).
The Sensitherm probe has been safely and successfully
used in more than 200,000 ablation procedures, so there is no
need to say more about it. Checking esophageal temperature
is an absolute necessity, despite the implicitly negative
advice of the article, as confirmed by the most important
reports on ablation-related esophageal lesions. Therefore, it
is important that clinicians receive a clear message: Please,
use any esophageal probe you like, but do it! OK, your
patient may get a mild irritation. Are you ready to exchange
this with the risk that temperature goes out of control?
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physiol 2015;26:556–564.To the Editor— Are esophageal lesions
caused by the use of esophageal probes or
conductive heat after atrial fibrillation
ablation?We read with interest the study by Müller et al1 on higher
incidence of esophageal lesions after atrial fibrillation abla-
tion and the use of Sensitherm esophageal probe (ETP).
Contrary to their findings, the findings of our computer
modeling study2 suggest that temperature rises in the
esophageal wall and the ETP were primarily produced by
thermal conduction and not by electrical and/or thermal
interactions between the ablation catheter and the ETP.
A slight alteration in the electrical field was noted only when
metallic surface probes (ETPs of Müller et al) were used.2
Esophageal thermal injury is thought to occur when
temperature450ºC is reached in a sufficiently large volume
of the esophageal wall to induce coagulative necrosis.
The findings of Müller et al are compatible with this
explanation because endoscopically detected esophageal
lesions (EDELs) were found in patients with esophageal
temperature higher (by 0.8ºC) than that in those without
EDELs. The proximity of the ablating electrode to the
esophageal wall encountered in most patients supports the
notion that thermal lesions created by radiofrequency energy
